Concepedia

Jenifer Borgognoni

JB

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2005

Affiliations

Granta Design (United Kingdom)(Current)

Institute of Cancer Research

Jenifer Borgognoni is an author at Granta Design (United Kingdom) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2005–2011

8

Publications

8

4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

Paul A. Brough, Wynne Aherne, Xavier Barril et al. · Journal of Medicinal Chemistry · 2007 · 445 citations · Full text

, , +11

Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design

D.S. Williamson, Jenifer Borgognoni, Alexandra Clay et al. · Journal of Medicinal Chemistry · 2009 · 229 citations · Full text

, , +14

Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-<i>d</i>]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone

Paul A. Brough, Xavier Barril, Jenifer Borgognoni et al. · Journal of Medicinal Chemistry · 2009 · 173 citations · Full text

, , +17

Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity

Alba T. Macias, D.S. Williamson, Nicola J. Allen et al. · Journal of Medicinal Chemistry · 2011 · 114 citations · Full text

, , +15

Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR

Christine M. Richardson, D.S. Williamson, Martin J. Parratt et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 69 citations · Full text

, , +14

1–5 of 8